XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/boston/2020/09/30/invetx-appoints-bill-brondyk-colin-giles-to-executive-team/60%Monthly2020-09-30 20:12
https://xconomy.com/boston/2020/09/30/thrive-earlier-detection-taps-cvss-asgarian-as-chief-medical-officer/60%Monthly2020-09-30 20:05
https://xconomy.com/new-york/2020/09/30/pfizer-pumps-200m-into-cstone-for-rights-to-pd-l1-cancer-drug-in-china/60%Monthly2020-10-05 17:53
https://xconomy.com/new-york/2020/09/30/with-phase-2-data-in-hand-ovid-eyes-multiple-fda-filings-for-epilepsy-drug/60%Monthly2020-09-30 12:13
https://xconomy.com/europe/2020/09/29/orphazyme-stock-sale-reaps-83m-as-neimann-pick-drug-review-begins/60%Monthly2020-09-29 15:26
https://xconomy.com/boston/2020/09/28/praxis-precision-medicines-leads-way-as-three-more-biotechs-prep-ipos/60%Monthly2020-09-28 21:34
https://xconomy.com/boston/2020/09/28/ex-radius-health-exec-carmona-joins-rubius-as-chief-financial-officer/60%Monthly2020-09-28 13:21
https://xconomy.com/europe/2020/09/28/freeline-therapeutics-promotes-corbau-to-chief-scientific-officer/60%Monthly2020-09-28 13:17
https://xconomy.com/europe/2020/09/25/galecto-picks-up-64m-as-plans-for-fibrosis-clinical-trials-move-forward/60%Monthly2020-09-26 18:12
https://xconomy.com/national/2020/09/25/bio-roundup-grail-acquisition-libras-launch-tau-trial-results-more/60%Monthly2020-09-25 15:48
https://xconomy.com/national/2020/09/25/combined-therapeutics-wins-250000-milliporesigma-advance-biotech-grant/60%Monthly2020-09-30 08:46
https://xconomy.com/boston/2020/09/24/monte-rosa-raises-96m-for-glue-based-protein-degrading-drugs/60%Monthly2020-09-26 18:18
https://xconomy.com/national/2020/09/24/2020-national-xconomy-awards-winners/60%Monthly2020-10-07 15:19
https://xconomy.com/san-diego/2020/09/23/libra-strikes-a-balance-with-approach-to-als-and-other-neuro-disorders/60%Monthly2020-09-23 23:25
https://xconomy.com/europe/2020/09/23/tau-targeting-alzheimers-drug-from-ac-immune-roche-fails-in-phase-2/60%Monthly2020-09-24 09:28
https://xconomy.com/seattle/2020/09/23/athira-ceo-kawas-alzheimers-drug-aims-for-recovery-of-brain-function/60%Monthly2020-09-23 11:57
https://xconomy.com/national/2020/09/22/gene-therapy-firms-seek-clarity-on-fda-exclusivity-orphan-designations/60%Monthly2020-09-22 13:00
https://xconomy.com/boston/2020/09/21/xconomy-awards-on-demand-meet-the-finalists-webcast-series-launches-this-week/60%Monthly2020-09-21 14:42
https://xconomy.com/san-francisco/2020/09/21/illumina-to-acquire-cancer-diagnostics-developer-grail-in-8b-deal/60%Monthly2020-09-21 19:53
https://xconomy.com/national/2020/09/18/bio-roundup-seagen-scores-dynes-debut-microbiome-moves-more/60%Monthly2020-09-18 18:12
https://xconomy.com/boston/2020/09/17/dynes-upsized-ipo-brings-in-233m-for-muscle-disorders-drug-rd/60%Monthly2020-09-17 17:03
https://xconomy.com/boston/2020/09/17/bio-chief-reckless-executive-order-on-drug-prices-threatens-innovation/60%Monthly2020-09-17 14:31
https://xconomy.com/boston/2020/09/17/finch-therapeutics-fetches-90m-to-advance-microbiome-drug-pipeline/60%Monthly2020-09-17 13:38
https://xconomy.com/wisconsin/2020/09/16/arrowhead-pharma-shares-soar-on-early-liver-data-for-rnai-drug/60%Monthly2020-09-16 17:39
https://xconomy.com/boston/2020/09/16/moderna-cmo-talks-covid-19-vaccine-at-xcelerate-next-week/60%Monthly2020-09-21 14:43
https://xconomy.com/europe/2020/09/15/neogene-therapeutics-grabs-110m-to-tackle-solid-tumors-with-cell-therapy/60%Monthly2020-09-15 23:02
https://xconomy.com/san-francisco/2020/09/15/unity-bio-restructuring-cuts-30-of-staff-keeps-focus-on-eye-drug/60%Monthly2020-09-15 14:57
https://xconomy.com/europe/2020/09/14/silence-therapeutics-taps-orchards-mark-rothera-as-president-ceo/60%Monthly2020-09-14 21:28
https://xconomy.com/boston/2020/09/14/synlogic-names-meteras-david-hava-as-chief-scientific-officer/60%Monthly2020-09-14 21:19
https://xconomy.com/seattle/2020/09/14/seattle-genetics-lands-1-72b-from-merck-in-pair-of-cancer-drug-deals/60%Monthly2020-09-14 19:51
https://xconomy.com/san-francisco/2020/09/14/gilead-adds-cornerstone-cancer-drug-in-21b-immunomedics-buyout/60%Monthly2020-09-14 15:18
https://xconomy.com/boston/2020/09/14/final-agenda-now-live-for-the-xcelerate-keynote-series-at-biotech-week-boston/60%Monthly2020-09-14 15:59
https://xconomy.com/national/2020/09/11/bio-roundup-covid-19-pact-gavreto-approval-generative-biology-more/60%Monthly2020-09-11 19:37
https://xconomy.com/boston/2020/09/10/now-closer-to-clinical-trials-codiak-biosciences-refiles-ipo-plans/60%Monthly2020-09-10 21:51
https://xconomy.com/san-francisco/2020/09/10/satsuma-pharmas-migraine-drug-fails-to-beat-placebo-in-phase-3-test/60%Monthly2020-09-10 23:35
https://xconomy.com/boston/2020/09/10/generate-bio-aims-to-reveal-natures-protein-secrets-create-new-drugs/60%Monthly2020-09-22 19:03
https://xconomy.com/national/2020/09/09/grail-files-to-go-public-4-more-life-science-firms-join-the-ipo-queue/60%Monthly2020-09-28 22:31
https://xconomy.com/boston/2020/09/08/agios-exec-andrew-hirsch-jumps-to-c4-therapeutics-for-ceo-role/60%Monthly2020-09-08 22:20
https://xconomy.com/boston/2020/09/08/allovir-taps-mercks-atillasoy-as-chief-regulatory-safety-officer/60%Monthly2020-09-08 22:12
https://xconomy.com/san-francisco/2020/09/08/grifols-moves-deeper-into-proteome-rd-with-146m-deal-for-alkahest/60%Monthly2020-09-09 07:56
https://xconomy.com/boston/2020/09/05/fda-approves-blueprint-cancer-drug-targeting-ret-genetic-signatures/60%Monthly2020-09-12 18:06
https://xconomy.com/national/2020/09/05/qa-bio-ceo-michelle-mcmurray-heath-outlines-diversity-goals/60%Monthly2020-09-08 21:04
https://xconomy.com/national/2020/09/04/abbvie-strikes-deal-for-i-mab-drug-with-a-potential-edge-in-cd47-chase/60%Monthly2020-09-30 16:45
https://xconomy.com/national/2020/09/04/bio-roundup-pharma-ma-abbvies-cancer-bet-biofourmis-bucks-more/60%Monthly2020-09-05 02:36
https://xconomy.com/boston/2020/09/03/biofourmis-hauls-in-100m-to-scale-digital-therapeutics-globally/60%Monthly2020-09-10 04:32
https://xconomy.com/seattle/2020/09/02/lumen-bioscience-lands-16m-to-engineer-edible-antibody-drugs/60%Monthly2020-09-03 21:16
https://xconomy.com/national/2020/09/02/new-podcast-and-special-report-explore-how-ai-is-revolutionizing-drug-discovery-and-development/60%Monthly2020-09-02 19:07
https://xconomy.com/new-york/2020/09/01/reeling-from-fda-rejection-intercept-pharma-slashes-headcount-by-25/60%Monthly2020-09-02 16:50
https://xconomy.com/san-francisco/2020/09/01/gilead-sciences-places-120m-bet-on-a-jounce-therapeutics-cancer-drug/60%Monthly2020-09-01 16:16